Company page
Kezar Life Sciences, Inc.
Kezar Life Sciences, Inc. is a public company traded under the ticker KZR in the American market. The company has a market capitalization of approximately $53.86 million. Kezar focuses on developing innovative therapies for autoimmune diseases and cancer.
- Ticker
- KZR:NASDAQ
- Asset type
- Stock
- Market cap
- $53.9M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD